Researchers at the Montreal Heart Institute announced today results showing that patients with cardiovascular disease and the appropriate genetic background benefit greatly from the new medication dalcetrapib, with a reduction of 39% in combined clinical outcomes including heart attacks, strokes, unstable angina, coronary revascularizations and cardiovascular deaths.
These patients also benefit from a reduction in the amount of atherosclerosis (thickened walls) in their vessels. The detailed results are published in the prestigious Journal Circulation Cardiovascular Genetics. This discovery may also pave the way for a new era in cardiovascular medicine, with personalized or precision drugs.
The team led by Drs Jean-Claude Tardif and Marie-Pierre Dubé performed the analysis of 5749 patients who received dalcetrapib or placebo and provided DNA in a clinical study. A strong association was discovered between the effects of dalcetrapib and a specific gene called ADCY9 (adenylate cyclase 9) on chromosome 16, particularly for a specific genetic variant (rs1967309). In patients with the genetic profile AA at rs1967309, there was a 39% reduction in the composite cardiovascular endpoint with dalcetrapib compared to placebo. Supporting evidence was also obtained from a second study, which showed that patients with the favourable genetic profile also benefited from a reduction in the thickness of their carotid artery walls with dalcetrapib.
“These results will lead to a genetics-guided clinical study in patients with the appropriate genetic background to allow review by health regulatory agencies and to provide personalized therapy with dalcetrapib. It also offers great hope for precision treatments for patients with cardiovascular diseases and for curbing atherosclerosis, the first cause of mortality in the world” said lead investigator Jean-Claude Tardif MD, director of the Research Center at the Montreal Heart Institute and professor of medicine at the University of Montreal.
The Latest on: Therapy for cardiovascular disease
[google_news title=”” keyword=”therapy for cardiovascular disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Therapy for cardiovascular disease
- High blood pressure? A heart app prescribes musical therapyon January 31, 2023 at 11:10 am
Europe has gone from thinking music could stop plagues 400 years ago to realizing it can help prevent cardiovascular disease today.
- Institute leads study on treatment for mitral valve diseaseon January 31, 2023 at 10:29 am
A team of researchers led by Vinay Badhwar, M.D., professor and executive chair of the WVU Heart and Vascular Institute, and including J. Hunter Mehaffey, M.D., assistant professor in the ...
- Celiac Disease Could Raise Heart Risks, Study Findson January 31, 2023 at 8:58 am
TUESDAY, Jan. 31, 2023 (HealthDay News) -- People with celiac disease may be more likely to develop heart disease despite having fewer traditional heart risks than other folks.
- WVU Heart and Vascular Institute team leads national study on optimal treatment for mitral valve diseaseon January 31, 2023 at 6:50 am
A team of researchers led by Vinay Badhwar, M.D., professor and executive chair of the WVU Heart and Vascular Institute, and including J. Hunter Mehaffey, M.D., assistant ...
- Watch: Service dog remains close to man diagnosed with heart disease in heart-warming videoon January 30, 2023 at 10:02 pm
A post shared by Magnus The Therapy Dog (@magnusthetherapydog ... Benson believes his case could be due to a family history of heart disease and heart attacks at a young age. "Even though I have been ...
- Treatment for gum disease may not benefit heavy smokerson January 30, 2023 at 6:43 am
Treatments for gum disease may have little benefit for heavy smokers, new research shows. The study findings suggest the need to rethink treatment of the common gum disease periodontitis, according to ...
- New Data Indicates That Viagra May Protect Against Heart Diseaseon January 30, 2023 at 3:29 am
The general population of men who had taken ED drugs had a 13% lower rate of MACE, 25% lower rate of mortality and 39% lower rate of CV mortality when compared to men who had not been exposed to ED ...
- New Guidelines Aim To Prevent Heart Problems in Children Undergoing Cancer Treatmenton January 30, 2023 at 2:56 am
The world’s first international clinical guidelines to help prevent and treat heart complications in children undergoing cancer treatment have been created.
- Congenital Heart Disease Treatment Device Market Industry Analysis Database for Period from 2023-2027on January 30, 2023 at 2:11 am
The “Congenital Heart Disease Treatment Device Market” Analysis 2023-2027 is a detailed sketch of the business sphere ...
- World-first guidelines created to help prevent heart complications in children during cancer treatmenton January 29, 2023 at 11:54 am
The world's first international clinical guidelines to help prevent and treat heart complications in children undergoing cancer treatment have been created.
via Bing News